TYRATyra Biosciences, Inc.

$26.23

Who owns TYRA

164 institutions reported holding TYRA for 2026Q1, together 107% of the company, more than the 131 a quarter earlier.

164

Institutions reporting a position · as of 2026Q1 · up from 131 the quarter before

Shares held by institutions
65.9M

Shares held by institutions · 107% of the company · long US equity positions only, as reported on Form 13F

Reported value
$2.52B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
51%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
19
New positions
40
Positions exited
13
Added to
56
Reduced
35
Top 10 holdersof the company
73%
Institutional ownership by quarter, 2021Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q116465.9M$2.52B
2025Q413156.8M$1.49B
2025Q311455.6M$778M
2025Q212056.6M$541M
2025Q111653.6M$500M
2024Q411248.6M$676M
2024Q39547.1M$1.11B
2024Q27946.8M$749M
2024Q17746.9M$768M
2023Q46235.8M$495M
2023Q35936.5M$502M
2023Q25836.2M$617M
2023Q15135.7M$573M
2022Q44635.2M$268M
2022Q34935.7M$314M
2022Q24835.7M$256M
Largest reported holders, 2026Q1
HolderShares% of companyValue
RA CAPITAL MANAGEMENT, L.P.12.2M20%$467M
FMR LLC7.7M13%$297M
Nextech Invest, Ltd.4.1M6.6%$155M
HENDERSON GROUP PLC3.9M6.3%$149M
Alta Partners Management Company, L.P.3.8M6.2%$146M
FARALLON CAPITAL MANAGEMENT LLC3.6M5.8%$137M
TCG Crossover Management, LLC3.2M5.3%$124M
Commodore Capital LP2.5M4.0%$95M
BlackRock Inc.2.2M3.6%$85M
Paradigm Biocapital Advisors LP2.1M3.3%$79M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…